This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Patrick P. Gleason, PharmD, BCPS, FCCP
Advertisement
Articles by Patrick P. Gleason, PharmD, BCPS, FCCP
Advertisement
Latest Updated Articles
- A Linezolid Prior Authorization Program: Clinical and Economic Outcomes
Published: April 16th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
FDA Approves Blenrep for Treatment of Relapsed or Refractory Multiple Myeloma
3
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
4
Hormone Therapy Use, Understanding, and Perceptions Have Positively Shifted From 2021 to 2025
5
